Status:
RECRUITING
Association of Near Infrared Spectroscopy With Interstage Outcomes
Lead Sponsor:
Advocate Hospital System
Conditions:
Single-ventricle
Eligibility:
All Genders
Up to 6 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the utility of renal near infrared spectroscopy in the outpatient setting during the interstage period. The primary aim will be to determine the correlation betw...
Detailed Description
As above
Eligibility Criteria
Inclusion
- Infants under 6 months of age
- Infants with single ventricle heart disease and parallel circulation
- Infants who are awaiting the Glenn operation
- Infants who are outpatient
Exclusion
- Infants over 6 months of age
- Inpatients
- Infants with history of skin injury from the near infrared spectroscopy sensor inpatient
- Infants with ongoing hyperbilirubinemia
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06538571
Start Date
July 1 2024
End Date
July 1 2026
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advocate Childrens Hospital
Oak Lawn, Illinois, United States, 60453